Document Detail


Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury.
MedLine Citation:
PMID:  17494883     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute kidney injury (AKI) remains a frequent and serious complication of human sepsis that contributes significantly to mortality. For better understanding of the development of AKI during sepsis, the cecal ligation and puncture (CLP) murine model of sepsis was studied using intravital video microscopy (IVVM) of the kidney. IVVM with FITC-dextran was used to determine the percentage of capillaries with continuous, intermittent or no flow at 0 (sham), 10, 16, and 22 h after CLP. There was a dramatic fall in capillary perfusion as early as 10 h after CLP that persisted through 22 h. The percentage of vessels with continuous flow at 16 h decreased from 73 +/- 2% in shams to 16 +/- 2% (P < 0.05), whereas the percentage of vessels with no flow increased from 4 +/- 1% in shams to 42 +/- 2% (P < 0.05). The capillary perfusion defect preceded the rise in serum creatinine. IVVM with dihydrorhodamine-123 was used to quantify in real time reactive nitrogen species (RNS) generation by renal tubules, and the inducible nitric oxide synthase inhibitor L-iminoethyl-lysine (mg/kg) was used to examine the role of inducible nitric oxide synthase inhibitor on capillary dysfunction and RNS generation. Tubular generation of RNS was significantly elevated at 10 h after CLP and was associated with tubules that were bordered by capillaries with reduced perfusion. L-iminoethyl-lysine significantly reversed the capillary perfusion defect, blocked RNS generation, and reduced AKI. These data show that capillary dysfunction and RNS generation contribute to tubular injury and suggest that RNS should be considered a potential therapeutic target in the treatment of sepsis-induced AKI.
Authors:
Liping Wu; Neriman Gokden; Philip R Mayeux
Related Documents :
2841243 - Effect of chemotactic agents on rat and guinea pig eosinophil cytotoxicity in vitro.
1589433 - Trypanocidal drugs and their effect on parasitaemia, specific igg production and protec...
1125493 - Stimulation of the hypothalamo-pituitary-adrenal axis by compounds formed in inflamed t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-05-09
Journal Detail:
Title:  Journal of the American Society of Nephrology : JASN     Volume:  18     ISSN:  1046-6673     ISO Abbreviation:  J. Am. Soc. Nephrol.     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-28     Completed Date:  2007-12-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9013836     Medline TA:  J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1807-15     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 West Markham Street #611, Little Rock, AR 72205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Animals
Capillaries / metabolism*
Cecum / injuries
Disease Models, Animal
Enzyme Inhibitors / pharmacology
Kidney Diseases / drug therapy,  metabolism*,  physiopathology
Kidney Tubules / blood supply,  metabolism*
Lysine / analogs & derivatives,  pharmacology
Male
Mice
Mice, Inbred C57BL
Microscopy, Video
Nitric Oxide / metabolism
Nitric Oxide Synthase Type II / antagonists & inhibitors,  metabolism
Reactive Nitrogen Species / metabolism*
Reactive Oxygen Species / metabolism
Renal Circulation / physiology*
Sepsis / metabolism*
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/N(6)-(1-iminoethyl)lysine; 0/Reactive Nitrogen Species; 0/Reactive Oxygen Species; 10102-43-9/Nitric Oxide; 56-87-1/Lysine; EC 1.14.13.39/Nitric Oxide Synthase Type II; EC 1.14.13.39/Nos2 protein, mouse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  How fibroblast growth factor 23 works.
Next Document:  Survival among patients with kidney failure in Jalisco, Mexico.